News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) to Participate in the UBS Global Life Sciences Conference



9/13/2012 10:07:25 AM

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the UBS Global Life Sciences Conference, being held September 19-20, 2012 at the Grand Hyatt in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Thursday, September 20 at 9:00 AM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® and the angioedema franchise, as well as the Licensing and Funded Research Program (LFRP).

Read at BioSpace.com


comments powered by Disqus
UBS
Dyax Corp.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES